All Stories

  1. Solid Fuel Use and Health in Developing Countries
  2. An Educational Activity on Trauma Informed Care for Healthcare Learners
  3. The prevalence of onchocerciasis in Africa and Yemen, 2000–2018: a geospatial analysis
  4. Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  5. Burden of diabetes and hyperglycaemia in adults in the Americas, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  6. The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019
  7. Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019
  8. Substance Use Disorders and Antisocial Personality Disorder among a Sample of Incarcerated Individuals with Inadequate Health Care: Implications for Correctional Mental-Behavioural Health and Addiction Services
  9. Demographic and clinical characteristics of lithium‐treated older adults with bipolar disorder
  10. Estimates, trends, and drivers of the global burden of type 2 diabetes attributable to PM2·5 air pollution, 1990–2019: an analysis of data from the Global Burden of Disease Study 2019
  11. Adolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019
  12. A Scoping Review on Barriers to Mental Healthcare in Canada as Identified by Healthcare Providers
  13. Insights About Cannabis and Psychosis Using Video Games for Young People With a First Episode of Psychosis, Particularly Those From Black Racialized Communities: Protocol for a Mixed Methods Study
  14. Anti-stigma training and positive changes in mental illness stigma outcomes in medical students in ten countries: a mediation analysis on pathways via empathy development and anxiety reduction
  15. Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  16. Global, regional, and national burden of diseases and injuries for adults 70 years and older: systematic analysis for the Global Burden of Disease 2019 Study
  17. Metabolism and risk
  18. Insights About Cannabis and Psychosis Using Video Games for Young People With a First Episode of Psychosis, Particularly Those From Black Racialized Communities: Protocol for a Mixed Methods Study (Preprint)
  19. Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019
  20. Cognition in older adults with bipolar disorder: An ISBD task force systematic review and meta‐analysis based on a comprehensive neuropsychological assessment
  21. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019
  22. Pharmacological interventions for alcohol misuse in correctional settings: A systematic review
  23. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019
  24. Combining Asian and American pedagogy to improve clinical psychopharmacology practice
  25. P.0415 Meta-analysis of cognitive performance in older adults with bipolar disorders
  26. A Student-Driven Advocacy Project to Address the Opioid Crisis in Canada: Implications for Developing Competency in Health Advocacy During Medical Training
  27. Global, regional, and national sex-specific burden and control of the HIV epidemic
  28. Mapping Anemia in Women: Global Trends and Inequality
  29. Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019
  30. Healthcare professionals need to be CCLEAR: Climate collaborators, leaders, educators, advocates, and researchers
  31. Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  32. Tracking development assistance for health and for COVID-19
  33. Global, regional, and national sex differences in the global burden of tuberculosis by HIV status
  34. Global, regional, and national burden of bone fractures in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
  35. Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019
  36. Use of multidimensional item response theory methods for dementia prevalence prediction: an example using the Health and Retirement Survey and the Aging, Demographics, and Memory Study
  37. Measuring routine childhood vaccination coverage in 204 countries and territories
  38. Promoting climate change issues in medical education: Lessons from a student-driven advocacy project in a Canadian Medical school
  39. Psychological distress and sleep problems in healthcare workers in a developing context during COVID-19 pandemic: Implications for workplace wellbeing
  40. Predicting the environmental suitability for onchocerciasis in Africa as an aid to elimination planning
  41. A comparative study of perceived burden in parent caregivers of adolescents with epilepsy in a resource-restricted setting: Investigating the explanatory factors of perceived burden
  42. Mapping inequalities in exclusive breastfeeding in low- and middle-income countries, 2000–2018
  43. Public health utility of cause of death data: applying empirical algorithms to improve data quality
  44. Subnational mapping of HIV incidence and mortality among individuals aged 15–49 years in sub-Saharan Africa, 2000–18: a modelling study
  45. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
  46. Spatial, temporal, and demographic patterns in prevalence of chewing tobacco use in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
  47. Hearing loss prevalence and years lived with disability
  48. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study
  49. Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study
  50. Mapping subnational HIV mortality in six Latin American countries with incomplete vital registration systems
  51. Global mortality from dementia: Application of a new method and results from the Global Burden of Disease Study 2019
  52. The Burden of Dementia due to Down Syndrome, Parkinson’s Disease, Stroke, and Traumatic Brain Injury: A Systematic Analysis for the Global Burden of Disease Study 2019
  53. Psychiatric Morbidity among Incarcerated Individuals in an Underserved Region of Nigeria: Revisiting the Unmet Mental Health Needs in Correction Services
  54. Mapping routine measles vaccination in low- and middle-income countries
  55. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
  56. Adolescent Substance Misuse/Use Disorders: Characteristic Features
  57. Sexual Offender Recidivism
  58. Absconsion in forensic psychiatric services: a systematic review of literature
  59. Five insights from the Global Burden of Disease Study 2019
  60. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019
  61. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  62. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  63. Self-stigma and decision about medication use among a sample of Nigerian outpatients with schizophrenia.
  64. Mapping geographical inequalities in access to drinking water and sanitation facilities in low-income and middle-income countries, 2000–17
  65. The global distribution of lymphatic filariasis, 2000–18: a geospatial analysis
  66. Estimating global injuries morbidity and mortality: methods and data used in the Global Burden of Disease 2017 study
  67. Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000–17
  68. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  69. Psychosocial Wellbeing of Nigerian Teachers in Special Education Schools
  70. Author Correction: Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017
  71. Emotional distress among parent caregivers of adolescents with sickle cell disease: Association with patients and caregivers variables
  72. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
  73. Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000–17: analysis for the Global Burden of Disease Study 2017
  74. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
  75. Department of Error
  76. Global injury morbidity and mortality from 1990 to 2017: results from the Global Burden of Disease Study 2017
  77. Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017
  78. Implementation of risk assessment tools in psychiatric services
  79. Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3
  80. Global trends of hand and wrist trauma: a systematic analysis of fracture and digit amputation using the Global Burden of Disease 2017 Study
  81. The burden of unintentional drowning: global, regional and national estimates of mortality from the Global Burden of Disease 2017 Study
  82. GBD 2016. Occupational Carcinogens Collaborators
  83. Global and regional burden of chronic respiratory disease in 2016 arising from non-infectious airborne occupational exposures: a systematic analysis for the Global Burden of Disease Study 2016
  84. Global and regional burden of disease and injury in 2016 arising from occupational exposures: a systematic analysis for the Global Burden of Disease Study 2016
  85. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
  86. Canadian Burden of Skin Disease From 1990 to 2017: Results From the Global Burden of Disease 2017 Study
  87. Burden of injury along the development spectrum: associations between the Socio-demographic Index and disability-adjusted life year estimates from the Global Burden of Disease Study 2017
  88. Significant Burden and Psychological Distress Among Caregivers of Children With Nephrotic Syndrome: A Cross-Sectional Study
  89. Mapping child growth failure across low- and middle-income countries
  90. Quantifying risks and interventions that have affected the burden of diarrhoea among children younger than 5 years: an analysis of the Global Burden of Disease Study 2017
  91. Quantifying risks and interventions that have affected the burden of lower respiratory infections among children younger than 5 years: an analysis for the Global Burden of Disease Study 2017
  92. Mapping disparities in education across low- and middle-income countries
  93. Epidemiology of injuries from fire, heat and hot substances: global, regional and national morbidity and mortality estimates from the Global Burden of Disease 2017 study
  94. The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
  95. The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
  96. The global burden of non-typhoidal salmonella invasive disease: a systematic analysis for the Global Burden of Disease Study 2017
  97. Mapping 123 million neonatal, infant and child deaths between 2000 and 2017
  98. The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease study 2017
  99. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017
  100. Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017
  101. The global burden of childhood and adolescent cancer in 2017: an analysis of the Global Burden of Disease Study 2017
  102. Diseases, Injuries, and Risk Factors in Child and Adolescent Health, 1990 to 2017
  103. Department of Error
  104. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  105. Long-acting atypical antipsychotics in schizophrenia: A systematic review and meta-analyses of effects on functional outcome
  106. A longitudinal cohort study of symptoms and other concerns among Nigerian people with stages 3–5 chronic kidney diseases: study protocol
  107. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  108. Global, regional, and national burden of suicide mortality 1990 to 2016: systematic analysis for the Global Burden of Disease Study 2016
  109. Global, regional, and national burden of brain and other CNS cancer, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  110. Global, regional, and national burden of epilepsy, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  111. Responding to experienced and anticipated discrimination (READ): anti -stigma training for medical students towards patients with mental illness – study protocol for an international multisite non-randomised controlled study
  112. Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  113. Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  114. Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017
  115. Predictors of caregiver burden after stroke in Nigeria: Effect on psychosocial well-being
  116. Evidence-Based Practice in the Evaluation and Treatment of Sexual Offenders
  117. Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016
  118. Cognitive and Functional Assessment of Psychosis Stratification Study (CoFAPSS): Rationale, Design, and Characteristics
  119. Global, regional, and national burden of tuberculosis, 1990–2016: results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 Study
  120. Global, regional, and national burden of motor neuron diseases 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  121. Global, regional, and national burden of meningitis, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  122. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017
  123. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease ...
  124. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
  125. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
  126. Measuring progress of the health-related Sustainable Development Goals for 195 countries
  127. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017
  128. Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017
  129. Department of Error
  130. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016
  131. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016
  132. Global Mortality From Firearms, 1990-2016
  133. Clozapine and Psychosocial Function in Schizophrenia: A Systematic Review and Meta-Analysis
  134. Alcohol use and attributable disease burden in 195
  135. Does ceasing exercise induce depressive symptoms? A systematic review of experimental trials including immunological and neurogenic markers
  136. Measuring performance_Healthcare Access_Quality Index for 195 countries and territories
  137. Mental health services in Nigerian prisons: Lessons from a four-year review and the literature
  138. Internalized stigma in schizophrenia: a cross-sectional study of prevalence and predictors
  139. Post-stroke depression: Prevalence, associated factors and impact on quality of life among outpatients in a Nigerian hospital
  140. The prevalence and burden of mental and substance use disorders in Australia: Findings from the Global Burden of Disease Study 2015
  141. Evaluation of the roles of HIV co-infection and socio-demographic factors as determinants of Quality of Life among Nigerians with Tuberculosis
  142. Stress and training satisfaction among resident doctors in Nigeria: Any justification for a change in training policy?
  143. Department of Error
  144. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016
  145. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016
  146. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  147. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  148. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  149. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016
  150. Department of Error
  151. Disordered eating attitudes: demographic and clinico-anthropometric correlates among a sample of Nigerian students
  152. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015
  153. 322. Transcranial Magnetic Stimulation of the Dorsolateral Prefrontal Cortex: A Review of Methods and Utility in Psychiatry
  154. Medication adherence among Nigerians with schizophrenia: correlation between clinico-demographic factors and quality of life
  155. Medication adherence among Nigerians with schizophrenia: correlation between clinico-demographic factors and quality of life
  156. Relationship between anxiety disorders and domains of health related quality of life among Nigerians with breast cancer
  157. Autism spectrum disorder in a community-based sample with neurodevelopmental problems in Lagos, Nigeria
  158. Children with neurodevelopmental disorders: The burden and psychological effects on caregivers in Lagos, Nigeria
  159. Poststroke anxiety disorders in a Nigerian hospital: Prevalence, associated factors, and impacts on quality of life
  160. Disability among attendees with schizophrenia in a Nigerian hospital: further evidence for integrated rehabilitative treatment designs
  161. Disability among attendees with schizophrenia in a Nigerian hospital: further evidence for integrated rehabilitative treatment designs
  162. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  163. Child’s symptom burden and depressive symptoms among caregivers of children with cancers: an argument for early integration of pediatric palliative care
  164. Anxiety disorders in breast cancer: Prevalence, types, and determinants
  165. Psychological distress and emotional pain among adult attendees of a dental clinic: a case-control study
  166. Psychological distress and emotional pain among adult attendees of a dental clinic: a case-control study
  167. Pattern of anxiety psychopathology experienced among postgraduate medical trainees
  168. Late-life depression: Burden, severity and relationship with social support dimensions in a West African community
  169. Impact of emotional distress on caregivers burden among Nigerian children with Obstructive Adenotonsillar hypertrophy
  170. Assessment of Functioning among Nigerians with Schizophrenia in a Tertiary Health Facility: Influence of Psychopathology, Socio-demographic and Treatment Factors
  171. Interplay of Anxiety and Depression With Quality of Life in Endstage Renal Disease
  172. A cross-sectional evaluation of the correlation between disease severity and quality of life in chronic rhinosinusitis patients in Nigeria
  173. Abstract 3845: Symptoms burden in subjects with cervical cancer and supportive care:A view from a developing country
  174. Burnout among doctors in residency training in a tertiary hospital
  175. Suicidal Ideation among Attendees of a West African HIV Clinic
  176. Symptoms burden in subjects with cervical cancer and supportive care: Preliminary result from a developing country
  177. Autism in Nigeria: A call for action
  178. Correlates of depressive illness among the elderly in a mixed urban community in Lagos, Nigeria
  179. Toward the integration of comprehensive mental health services in HIV care: An assessment of psychiatric morbidity among HIV-positive individuals in sub-Saharan Africa
  180. Toward integration of palliative care into cancer care: A study on profile of psychosocial and clinical complications among attendees of a Nigerian oncological center.
  181. A comparative analysis of disability in individuals with bipolar affective disorder and schizophrenia in a sub-Saharan African mental health hospital: towards evidence-guided rehabilitation intervention
  182. 593 – Sociodemographic profile, presentations and therapeutic interventions in a community psychiatry service in south-west, nigeria
  183. A multi-dimensional assessment of quality of life among attendees of a West African HIV clinic and its use in tracking outcome
  184. Screening for depression with Centre for Epidemiological Studies Depression Scale Revised and its implication for consultation-liaison psychiatry practice among cancer subjects: a perspective from a developing country
  185. A Study on Epidemiological Profile of Anxiety Disorders Among People Living with HIV/AIDS in a Sub-Saharan Africa HIV Clinic
  186. Factors associated with anxiety disorders among HIV-positive attendees of an HIV clinic in Lagos, Nigeria
  187. HIV/AIDS and psychological distress: The experience of outpatients in a West African HIV clinic
  188. A Controlled Study of Depression among Attendees of an Oncology Clinic in West Africa
  189. Predictive and risk factors of depression in a Western African Oncology Clinic
  190. Incidence and correlates of delirium in a West African mental health clinic
  191. Erratum to “Prevalence and correlates of poor medication adherence amongst psychiatric outpatients in southwestern Nigeria” [General Hospital Psychiatry 31 (2009) 167–174]
  192. P01-270 - Quality of life and sociodemographic factors of patients with unexplained symptom in general practice
  193. P02-35 - Incidence and correlates of delirium in a west African mental health clinic
  194. P03-208 - Correlates and prevalence of substance use among primary care patient in Ikorodu, Nigeria
  195. Prevalence and correlates of poor medication adherence amongst psychiatric outpatients in southwestern Nigeria